Found 16 matching trials
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US PHASE4 Compare the IOP lowering properties of latanoprost, travoprost and bimatopr...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
PSLT Compared to Prostaglandin Analogue Eye Drops NA This study aims to compare the efficacy of PSLT and the topical use of pros...
Show More Location
Universidade Federal do Rio Grande do Sul
Learn More & Join Trial
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. PHASE4 The purpose of this study is to evaluate the potential secondary beneficial...
Show More Location
Stanford Hospital and Clinics
Learn More & Join Trial
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye PHASE4 The purpose of this study is to study changes in skin color that may be cau...
Show More Location
Arlington Eye Physicians
Learn More & Join Trial
Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves PHASE4 After implantation of an Ahmed glaucoma valve in patients with glaucoma, hy...
Show More Location
Credit Valley Eye Care
Learn More & Join Trial
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) N/A To investigate the effectiveness of the newer IOP-lowering therapies, as pr...
Show More Location
Multiple Locations
Learn More & Join Trial
Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma PHASE4 Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues PHASE4 This study will evaluate hyperemia and ocular surface tolerability in patie...
Show More Location
Multiple Locations
Learn More & Join Trial
Stop Retinal Ganglion Cell Dysfunction Study PHASE3 Glaucoma is a progressive disease resulting in blindness. Determining the o...
Show More Location
Bascom Palmer Eye Institute - University of Miami
Learn More & Join Trial
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% PHASE4 Patients with glaucoma or ocular hypertension currently being treated with ...
Show More Location
Multiple Locations
Learn More & Join Trial